4-nitro-N-(3,4,5-trimethoxyphenyl)benzothioamide | 1393816-21-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-nitro-N-(3,4,5-trimethoxyphenyl)benzothioamide
• 英文别名: 4-nitro-N-(3,4,5-trimethoxyphenyl)benzenecarbothioamide
• CAS: 1393816-21-1
• 化学式: C₁₆H₁₆N₂O₅S
• 分子量: 348.379
• InChiKey: ZGBJKDJACWLKHC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  118
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-nitro-N-(3,4,5-trimethoxyphenyl)benzothioamide 在 溶剂黄146 tin(II) chloride dihdyrate 、 sodium hydroxide 、 potassium hexacyanoferrate(III) 作用下， 以 乙醇 、 水 为溶剂， 反应 6.0h， 生成
  参考文献：
  名称：

  [EN] 2-PHENYL BENZOTHIAZOLE LINKED IMIDAZOLE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF
  [FR] COMPOSÉS D'IMIDAZOLE À LIAISON 2-PHÉNYLE BENZOTHIAZOLE COMME AGENTS ANTICANCÉREUX POTENTIELS ET LEUR PROCÉDÉ DE PRÉPARATION

  摘要：

  本发明提供了一种2-苯基苯并噻唑偶氮化合物，其化学式为A，作为抗癌药物，针对五十三种人类癌细胞系。其中（II）R=H或OCH3；R1=H，F或OCH3；R2=H或OCH3；R3=H，NH2，F或OCH3；R4=H，NH2或OCH3；R5=H，NH2，F，CF3或OCH3；R6=H或OCH3；R7=H或OCH3；R8=H或OCH3。

  公开号：

  WO2012110959A1
• 作为产物：
  描述：

  3-甲基-4-硝基苯甲酰氯 在 劳森试剂 、 吡啶 作用下， 以 甲苯 为溶剂， 反应 11.0h， 生成 4-nitro-N-(3,4,5-trimethoxyphenyl)benzothioamide
  参考文献：
  名称：

  2-Arylaminobenzothiazole-arylpropenone缀合物作为微管蛋白聚合抑制剂

  摘要：

  基于5F-203设计了一系列新的2-芳基氨基苯并噻唑-芳基丙烯酮共轭物，并对其细胞毒性和抑制微管蛋白聚合作用进行了评估。

  DOI：

  10.1039/c6md00562d

文献信息

• Synthesis and biological evaluation of cis -restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers
  作者：A.V. Subba Rao、Konderu Swapna、Siddiq Pasha Shaik、V. Lakshma Nayak、T. Srinivasa Reddy、Satish Sunkari、Thokhir Basha Shaik、Chandrakant Bagul、Ahmed Kamal

  DOI：10.1016/j.bmc.2016.12.010

  日期：2017.2

  bond was restricted by the incorporation of a triazole and tetrazole rings which is envisaged by the structural resemblance to a tubulin inhibitor like combretastatin (CA-4). These compounds were evaluated for their antiproliferative activity on selected cancer cell lines and an insight in the structure activity relationship was developed. The most potent compounds (9a and 9b) demonstrated an antiproliferative

  通过修饰康维他汀药效团合成了一系列秋水仙碱位点结合微管蛋白抑制剂。环B被药理学上相关的苯并噻唑支架取代，烯键的顺式构型受到三唑和四唑环的结合的限制，这可以通过与微管蛋白抑制剂（如康培他汀（CA-4））的结构相似来实现。评估了这些化合物对所选癌细胞系的抗增殖活性，并开发了对结构活性关系的见解。最有效的化合物（9a和9b）具有与CA-4相当的抗增殖作用。G2 / M期的有丝分裂细胞周期停滞揭示了微管动力学的破坏，这已在细胞水平上通过微管蛋白聚合测定法和免疫细胞化学研究得到证实。蛋白质印迹分析表明，这些化合物在可溶性级分中积累了更多的微管蛋白。秋水仙碱竞争性结合试验和分子对接研究表明，这些模拟物在微管蛋白的秋水仙碱位点的结合与CA-4相似。此外，通过Hoechst染色，膜联蛋白-V-FITC分析，线粒体膜电位，ROS生成和caspase-3活化来研究其对有丝分裂阻滞后凋亡细胞死亡的触发作用。
• 2-PHENYL BENZOTHIAZOLE LINKED IMIDAZOLE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF
  申请人：Ahmed Kamal

  公开号：US20150141657A1

  公开（公告）日：2015-05-21

  The present invention provides 2-phenyl benzothiazole linked imidazole compounds of formula A as anti cancer agent against fifty three human cancer cell lines. wherein

  本发明提供了公式A的2-苯基苯并噻唑连接的咪唑化合物，作为抗癌剂用于对抗53种人类癌细胞系。其中：
• Synthesis and study of benzothiazole conjugates in the control of cell proliferation by modulating Ras/MEK/ERK-dependent pathway in MCF-7 cells
  作者：Ahmed Kamal、Shaikh Faazil、M. Janaki Ramaiah、Md. Ashraf、M. Balakrishna、S.N.C.V.L. Pushpavalli、Nibedita Patel、Manika Pal-Bhadra

  DOI：10.1016/j.bmcl.2013.07.068

  日期：2013.10

  By applying a methodology, a series of benzothiazole-pyrrole based conjugates (4a-r) were synthesized and evaluated for their antiproliferative activity. Compounds such as 4a, 4c, 4e, 4g-j, 4m, 4n, 4o and 4r exhibited significant cytotoxic effect in the MCF-7 cell line. Cell cycle effects were examined for these conjugates at 2 mu M as well as 4 mu M concentrations and FACS analysis show an increase of G2/M phase cells with concomitant decrease of G1 phase cells thereby indicating G2/M cell cycle arrest by them. Interestingly 4o and 4r are effective in causing apoptosis in MCF-7 cells. Moreover, 4o showed down regulation of oncogenic expression of Ras and its downstream effector molecules such as MEK1, ERK1/2, p38 MAPK and VEGF. The apoptotic aspect of this conjugate is further evidenced by increased expression of caspase-9 in MCF-7 cells. Hence these small molecules have the potential to control both the cell proliferation as well as the invasion process in the highly malignant breast cancers. (C) 2013 Elsevier Ltd. All rights reserved.
• US9187467B2
  申请人：——

  公开号：US9187467B2

  公开（公告）日：2015-11-17
• 2-Arylaminobenzothiazole-arylpropenone conjugates as tubulin polymerization inhibitors
  作者：A. V. Subba Rao、Bala Bhaskara Rao、Satish Sunkari、Siddiq Pasha Shaik、Bajee Shaik、Ahmed Kamal

  DOI：10.1039/c6md00562d

  日期：——

  A new series of 2-arylaminobenzothiazole-arylpropenone conjugates were designed based on 5F-203, synthesized and evaluated for their cytotoxic potency as well as inhibition of tubulin polymerization.

  基于5F-203设计了一系列新的2-芳基氨基苯并噻唑-芳基丙烯酮共轭物，并对其细胞毒性和抑制微管蛋白聚合作用进行了评估。